Paper
19 July 1994 Light delivery and dosimetry for photodynamic therapy in an ovarian cancer mouse model
Author Affiliations +
Abstract
The Swiss nude mouse model is currently used as an animal model to investigate the efficacy of photodynamic therapy in ovarian cancer treatment. The disease requires treatment illumination of the entire abdominal cavity. The close proximity of the internal organs in the abdomen of a mouse and the vastly different optical properties of these organs present a challenge to light delivery and dosimetry. In this study the efficacy of different internal and transcutaneous light delivery geometries was investigated by scanning a transverse plane of the peritoneum with optical fiber fluence-rate detectors. The placement of the implanted optical fibers in the abdominal cavity was verified post mortem in selected animals by high resolution CT imaging. Preliminary experiments were performed to correlate the biological response with actual total fluence delivered to the abdominal cavity. Optical fiber fluence rate detectors were implanted in the peritoneum and abdominal cavity and the animal was treated with PDT. Cell survival of one hour post light treatment harvested cells from the peritoneum was used as a biological response quantifier.
© (1994) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Lothar D. Lilge, W. Dabrowski, David W. Holdsworth, J. Blake, D. Kato, Brian C. Wilson, and Tayyaba Hasan "Light delivery and dosimetry for photodynamic therapy in an ovarian cancer mouse model", Proc. SPIE 2133, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy III, (19 July 1994); https://doi.org/10.1117/12.179978
Lens.org Logo
CITATIONS
Cited by 5 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Sensors

Photodynamic therapy

Optical fibers

Liver

Mouse models

Cancer

Ovarian cancer

Back to Top